Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Amortizatization of Intangibles (2016 - 2025)

Sangamo Therapeutics (SGMO) has 16 years of Amortizatization of Intangibles data on record, last reported at -$1.8 million in Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 158.57% year-over-year to -$1.8 million; the TTM value through Sep 2025 reached $894000.0, up 449.22%, while the annual FY2024 figure was $4.3 million, 82.65% up from the prior year.
  • Amortizatization of Intangibles reached -$1.8 million in Q3 2025 per SGMO's latest filing, down from $904000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $10.6 million in Q4 2021 and bottomed at -$3.6 million in Q4 2023.
  • Average Amortizatization of Intangibles over 5 years is $1.2 million, with a median of $894000.0 recorded in 2024.
  • The widest YoY moves for Amortizatization of Intangibles: up 2141.04% in 2021, down 433.84% in 2021.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $10.6 million in 2021, then tumbled by 80.2% to $2.1 million in 2022, then crashed by 272.44% to -$3.6 million in 2023, then soared by 124.72% to $894000.0 in 2024, then tumbled by 302.24% to -$1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$1.8 million in Q3 2025, $904000.0 in Q2 2025, and $904000.0 in Q1 2025.